Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma exposed and/or refractory to prior alkylators - A pooled analysis of the O-12-M1 and HORIZON studies Meeting Abstract


Authors: Rodriguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Thuresson, M.; Harmenberg, J.; Harlin, O.; Richardson, P.
Abstract Title: Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma exposed and/or refractory to prior alkylators - A pooled analysis of the O-12-M1 and HORIZON studies
Meeting Title: 2021 Lymphoma, Leukemia & Myeloma Congress
Journal Title: American Journal of Hematology
Volume: 96
Issue: Suppl. 1
Meeting Dates: 2021 Oct 19-23
Meeting Location: Virtual
ISSN: 0361-8609
Publisher: John Wiley & Sons, Inc.  
Date Published: 2021-10-01
Start Page: S8
End Page: S9
Language: English
ACCESSION: WOS:000707408900011
PROVIDER: wos
PUBMED: 34652034
DOI: 10.1002/ajh.26351
Notes: Meeting Abstract: PO-9 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hani Hassoun
    334 Hassoun
Related MSK Work